Pelvic Organ Prolapse Surgery in Academic Female Pelvic Medicine and Reconstructive Surgery Urology Practice in the Setting of the Food and Drug Administration Public Health Notifications

Trends in pelvic organ prolapse management in Latin America

“…However, reports on complications led to the issuing of warnings and notifications from regulatory agencies worldwide . This resulted on massive media attention and the proliferation of legal activity directed at mesh products, which motivated several manufacturers to voluntarily withdraw their product from the market, reducing mesh use in the United States . This situation was followed by an introduction of new technologies and a renewed interest in traditional procedures .…”

“…7 This resulted on massive media attention and the proliferation of legal activity directed at mesh products, which motivated several manufacturers to voluntarily withdraw their product from the market, reducing mesh use in the United States. 8 This situation was followed by an introduction of new technologies and a renewed interest in traditional procedures. 9 In contrast, European countries have reported an increase in the use of surgical mesh for POP repair in recent years, 6 even though the Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR) launched a recommendation in 2015 stating that "the implantation of any mesh for the treatment of POP via the vaginal route should only be considered in complex cases, in particular, after failed primary repair surgery."…”

Stress urinary incontinence surgery trends in academic female pelvic medicine and reconstructive surgery urology practice in the setting of the food and drug administration public health notifications

“…Nevertheless, the effect of the FDA Safety Communications on surgical practice for SUI remains unclear. We recently showed that there has been a significant change in POP surgery in this practice setting over the last seven years, with a substantial reduction in transvaginal mesh augmented repair of POP as well as a simultaneous increase in the number of mesh revision surgeries . The objective of this study is to evaluate for changes in trends in SUI surgery, including sling revisions for mesh‐related complications among FPMRS specialists over the last 7 years at tertiary care medical centers across the United States.…”

Reasons for and Against Use of Non-absorbable, Synthetic Mesh During Pelvic Organ Prolapse Repair, According to the Prolapsed Compartment

“…Its prevalence is currently estimated to be approximately 40% in women 45–85 years of age, and around 30% of these women are symptomatic [2]. Symptomatic patients may complain of urinary, bowel, or sexual symptoms as well as symptoms of vaginal pressure, heaviness, or pain [3]. These symptoms have a major impact on patients’ physical and emotional well-being [4].…”